Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer

Fig. 1

Identification of candidate biomarkers for gastric cancer. A, B: The selection of key overlapping differentially expressed genes (DEGs) by least absolute shrinkage and selection operator (LASSO) regression analysis. C, D: The selection of key overlapping DEGs by random forest (RF) analysis. E: Venn diagram of key overlapping DEGs selected by LASSO regression and RF analysis

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us